Dongwha Pharm Co Ltd
KRX:000020

Watchlist Manager
Dongwha Pharm Co Ltd Logo
Dongwha Pharm Co Ltd
KRX:000020
Watchlist
Price: 6 140 KRW Market Closed
Market Cap: ₩171.5B

Operating Margin

1.4%
Current
Declining
by 3%
vs 3-y average of 4.5%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
1.4%
=
Operating Income
₩7.1B
/
Revenue
₩493.3B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
1.4%
=
Operating Income
₩7.1B
/
Revenue
₩493.3B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
Dongwha Pharm Co Ltd
KRX:000020
170.2B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
954.9B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
546.2B USD
Loading...
CH
Roche Holding AG
SIX:ROG
268.4B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.9B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
265.4B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
147.6B USD
Loading...
FR
Sanofi SA
PAR:SAN
94.4B EUR
Loading...

Market Distribution

In line with most companies in Korea
Percentile
42nd
Based on 2 615 companies
42nd percentile
1.4%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

Dongwha Pharm Co Ltd
Glance View

Market Cap
171.5B KRW
Industry
Pharmaceuticals

Dong Wha Pharm Co., Ltd. engages in the manufacture and sale of pharmaceuticals and medicinal chemicals. The company is headquartered in Seoul, Seoul. The Company’s products consist of ethical drugs, including digestive system remedies, antibiotics, cardiovascular and metabolic disease treatments, non steroidal anti-inflammatory drugs, respiratory remedies, muscle relaxants, nervous system remedies, dermatological remedies and urinary system remedies, and over-the-counter (OTC) drugs, including cold remedies, dental remedies, dermatological remedies, hepatic protectors, nutrients, tonics, topical analgesics, anti-smoking agents and others. The company also provides medicine raw materials, health food and drinks, as well as cosmetics. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
14 880.62 KRW
Undervaluation 59%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
1.4%
=
Operating Income
₩7.1B
/
Revenue
₩493.3B
What is Dongwha Pharm Co Ltd's current Operating Margin?

The current Operating Margin for Dongwha Pharm Co Ltd is 1.4%, which is below its 3-year median of 4.5%.

How has Operating Margin changed over time?

Over the last 3 years, Dongwha Pharm Co Ltd’s Operating Margin has decreased from 9.9% to 1.4%. During this period, it reached a low of 1.1% on Jun 30, 2025 and a high of 9.9% on Aug 30, 2022.

Back to Top